Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Latest News

Date posted: 8/27/2013

Despite the growing number of studies which suggest the blood thinning medication Pradaxa may have serious internal bleeding risks, the number of prescriptions for the drug continue to rise.

Now, records show the number of lawsuits filed by those affected by Pradaxa bleeding is growing nearly as fast as sales of the drug, pointing further to its danger.

Pradaxa was launched in 2010 as an alternative to warfarin to prevent blood clots and strokes in patients with atrial fibrillation. Although it didn’t require regular blood tests like warfarin, it also didn’t have an antidote to stop internal bleeding in emergencies, a common side effect of anticoagulants.

Before Pradaxa had been on the market one full year, the FDA had already received more injury reports than for 98% of all other drugs. It was also among the most commonly reported drugs for injuries and deaths in both 2011 and 2012.

This year, researchers from the University of Illinois and the Netherlands have warned that patients using Pradaxa may have higher risks of internal bleeding than expected. The Institute for Safe Medication Practices also called it one of the most dangerous drugs, since patients are almost 500% as likely to die from Pradaxa bleeding than warfarin bleeding.

Unfortunately, the FDA has stated Pradaxa is as safe as warfarin and they will not issue a Pradaxa recall.

In their latest financial report, drug maker Boehringer Ingelheim states that Pradaxa use is growing significantly, with sales up 27.9% in the first half of 2013. This comes after use of the drug grew more than 76% between from 2011 to 2012, when sales eclipsed $1 billion.

Fortunately, those injured by the drug have legal rights. A special federal court has been established to handle Pradaxa lawsuits.

Now, DrugRisk reports that the latest figures from the Judicial Panel on Multidistrict Litigation show the number of cases filed has increased from 1,133 on July 10th to 1,389 on August 15, a rise of over 22%.

These numbers suggest the more patients use Pradaxa, the more are injured.

If you or a loved one suffered internal bleeding or death after using Pradaxa, it is important to learn about your legal options as soon as possible. Lawyers are helping those affected at no cost and can discuss your case today.

DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits, due to the complexity of these federal cases. Contact us today for more information or to speak with a lawyer.